SCHEMBL16596187

SCHEMBL16596187

CCCCCCCCCCCC(=O)Nc1ccc2[nH]ccc2c1

nearest known ligand 0.70

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
EPHX1 P07099 1/20 0.70
NPC1 O15118 2/20 0.61
RAB9A P51151 2/20 0.61
LMNA P02545 1/20 0.61
SMN1; SMN2 Q16637 1/20 0.61
HDAC1 Q13547 3/20 0.60
HDAC2 Q92769 2/20 0.60
EGFR P00533 1/20 0.55
NOTUM Q6P988 1/20 0.54
MAOB P27338 2/20 0.53
MAOA P21397 3/20 0.52
ENPP2 Q13822 1/20 0.52
DGAT2 Q96PD7 1/20 0.52
CNR1 P21554 1/20 0.52
CNR2 P34972 1/20 0.52
MAPT P10636 1/20 0.51
HDAC3 O15379 1/20 0.49
HDAC4 P56524 1/20 0.49
HDAC7 Q8WUI4 1/20 0.49
HDAC10 Q969S8 1/20 0.49

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2535693 0.89 EPHX1 (0.61) EPHX1NPC1RAB9ALMNASMN1; SMN2
SCHEMBL9478935 0.88 HDAC1 (0.72) EPHX1NPC1RAB9ALMNASMN1; SMN2
SCHEMBL7441657 0.85 HDAC1 (0.83) EPHX1NPC1RAB9AHDAC1HDAC2
SCHEMBL9705403 0.84 MAOB (0.55) EPHX1NPC1RAB9AHDAC1HDAC2
SCHEMBL2535295 0.83 NOTUM (0.61) EPHX1NPC1RAB9AEGFRNOTUM
SCHEMBL5146715 0.82 EPHX1 (1.00) EPHX1NPC1RAB9AHDAC1HDAC2
SCHEMBL22803307 0.82 EPHX1 (1.00) EPHX1NPC1RAB9AHDAC1HDAC2
SCHEMBL22803313 0.82 EPHX1 (1.00) EPHX1NPC1RAB9AHDAC1HDAC2
SCHEMBL22803830 0.81 EPHX1 (0.97) EPHX1NPC1RAB9AMAOBMAOA
SCHEMBL22803310 0.80 EPHX1 (0.71) EPHX1NPC1RAB9AHDAC1MAOB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9751851-B2 Molecules and compositions that inhibit gram negative bacteria and their uses THE TRUSTEES OF PRINCETON UNIVERSITY (US) 2017-09-05 US disclosed
US-20160368892-A1 MOLECULES AND COMPOSITIONS THAT INHIBIT GRAM NEGATIVE BACTERIA AND THEIR USES THE TRUSTEES OF PRINCETON UNIVERSITY (US) 2016-12-22 US disclosed
WO-2015042363-A1 MOLECULES AND COMPOSITIONS THAT INHIBIT GRAM NEGATIVE BACTERIA AND THEIR USES THE TRUSTEES OF PRINCETON UNIVERSITY (US) 2015-03-26 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20160368892-A1 MOLECULES AND COMPOSITIONS THAT INHIBIT GRAM NEGATIVE BACTERIA AND THEIR USES BLVRB, PGLS, GRHPR EPHX1 2628/4885NPC1 4883/4885RAB9A 751/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.